BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Messori A, Fadda V, Maratea D, Trippoli S. Effect of discounting on estimation of benefits determined by hepatitis C treatment. World J Gastroenterol 2012; 18(23): 3032-3034 [PMID: 22736930 DOI: 10.3748/wjg.v18.i23.3032]
URL: https://www.wjgnet.com/1007-9327/full/v18/i23/3032.htm
Number Citing Articles
1
Andrea Messori, Dario Maratea, Valeria Fadda, Roberta Gatto, Sabrina Trippoli. An Italian perspectiveEuropean Journal of Gastroenterology & Hepatology 2014; 26(7): 813 doi: 10.1097/MEG.0000000000000107
2
A. Messori, D. Maratea, V. Fadda, S. Trippoli. Letter: estimating the cost‐neutral price of sofosbuvir‐based triple therapy for the treatment of naïve patients with genotype 1 HCV infection in ItalyAlimentary Pharmacology & Therapeutics 2014; 40(2): 217 doi: 10.1111/apt.12823
3
Mei H. Chang, Lori A. Gordon, Horatio B. Fung. Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis CClinical Therapeutics 2012; 34(10): 2021 doi: 10.1016/j.clinthera.2012.08.009